Global Bone Morphogenetic Protein (BMP) 2 Market Size, Status and Forecast 2020-2026

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive?one of the three main categories of bone grafts?and play an active role in bone formation and maintenance.
The classification of Bone Morphogenetic Protein (BMP) 2 includes sponge and gel types, and the proportion of sponge in 2016 is about 99%, and the proportion will be in decreasing trend from 2017 to 2022.
Bone Morphogenetic Protein (BMP) 2 is widely used in spinal fusion, trauma surgery, oral maxillofacial surgery and reconstructive. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used in spinal fusion, and the consumption proportion is about 62% in 2016.
North America is the largest consumption place, with a consumption market share nearly 70% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is concentrated. Medtronic and Cellumed are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bone Morphogenetic Protein (BMP) 2 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Bone Morphogenetic Protein (BMP) 2 industry.
Based on our recent survey, we have several different scenarios about the Bone Morphogenetic Protein (BMP) 2 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 402.1 million in 2019. The market size of Bone Morphogenetic Protein (BMP) 2 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone Morphogenetic Protein (BMP) 2 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone Morphogenetic Protein (BMP) 2 market in terms of revenue.
Players, stakeholders, and other participants in the global Bone Morphogenetic Protein (BMP) 2 market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Bone Morphogenetic Protein (BMP) 2 market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Bone Morphogenetic Protein (BMP) 2 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone Morphogenetic Protein (BMP) 2 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone Morphogenetic Protein (BMP) 2 market.
The following players are covered in this report:
    Medtronic
    Cellumed
    ...
Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Type
    Sponge
    Gel
Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Application
    Spinal Fusion
    Trauma Surgery
    Oral Maxillofacial Surgery
    Reconstructive